Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.
PHASE2CompletedINTERVENTIONAL
Enrollment
100
Participants
Timeline
Start Date
October 31, 1996
Study Completion Date
November 30, 1997
Conditions
Postoperative Pain
Interventions
DRUG
Buprenorphine transdermal delivery system
Trial Locations (1)
33324
Park Place Therapeutic Center, Plantation
All Listed Sponsors
lead
Purdue Pharma LP
INDUSTRY
NCT00315835 - Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery. | Biotech Hunter | Biotech Hunter